Syquant Capital’s Horizon Therapeutics HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-1,398,990
Closed -$162M – 14
2023
Q3
$162M Buy
1,398,990
+545,824
+64% +$58.6M 63.55% 1
2023
Q2
$87.7M Buy
853,166
+581,549
+214% +$61.4M 63.76% 1
2023
Q1
$29.6M Buy
+271,617
New +$30M 68.69% 1

Other funds holding HZNP

Syquant Capital's HZNP Position: Q4 2023 in Review

Syquant Capital sold out of Horizon Therapeutics (HZNP) in Q4 2023, closing a stake of 1,398,990 shares — an estimated $162M sold.

Syquant Capital first reported a position in HZNP in Q1 2023 and held it in 3 quarters. The position peaked at $162M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Syquant Capital reported no remaining Horizon Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Syquant Capital sold 1,398,990 Horizon Therapeutics shares in Q4 2023, an estimated $162M.
  • Syquant Capital first reported a position in Horizon Therapeutics in Q1 2023 and held it in 3 quarters.
  • Syquant Capital's Horizon Therapeutics position peaked at $162M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics as of Q4 2023.

Based on Syquant Capital's 13F filing for Q4 2023, filed 10 Jan 2024.